EUDA, VGG3142E1473

EUDA proposes 50-vote shares, changing EUDA stock governance

Published on 10/21/2026 at 06:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The proposal covers 2,000,000 Class B shares with 50 votes each. EUDA stock faces an October 30, 2026 vote after 437,824 shares were designated.

Voting structure and results

  • EUDA filed its extraordinary meeting notice on October 13, 2026, covering 2,000,000 Class B shares.
  • Each proposed Class B share would carry 50 votes, while 437,824 shares would be reclassified.
  • EUDA reported USD 1.73 million in second-quarter 2026 revenue against USD 9.61 million expected.
  • The extraordinary meeting is scheduled for October 30, 2026, with proxies due by October 29, 2026.
EUDA, VGG3142E1473, Illustration mit AI erstellt.

EUDA Health Holdings Limited (ISIN VGG3142E1473) proposed a dual-class structure with 2,000,000 Class B shares in a filing dated October 13, 2026. The notice, submitted to the U.S. Securities and Exchange Commission, sets an extraordinary general meeting for October 30, 2026, where shareholders will vote on the plan.

The proposal would give each Class B share 50 votes, compared with one vote for each Class A share. According to SEC filings, 437,824 shares held by Tan Meng Dong and 8i Capital would be reclassified as Class B shares, while 1,562,176 authorized but unissued shares would also receive that classification.

What changes with 50 votes?

If approved and filed, the proposal would leave Tan Meng Dong and 8i Capital with approximately 14.6 percent of outstanding shares but approximately 89.5 percent of voting power. The filing says this concentration could allow the holders to determine outcomes involving directors, mergers, control transactions and other major corporate actions.

The board recommends voting for all three proposals. The meeting will also cover amended governing documents and a possible adjournment if additional proxy solicitation is required. The governance change therefore carries a concrete control consequence for public shareholders, even before any vote takes place.

Results set a weaker baseline

EUDA's second-quarter 2026 results provide the operating backdrop. MarketBeat reported on September 29, 2026, that revenue was USD 1.73 million against USD 9.61 million expected, while earnings per share were minus USD 0.17 versus a consensus estimate of USD 0.40. The revenue shortfall was USD 7.88 million.

SEC records show that the relevant reporting period ended June 30, 2026. Cash was USD 365,904 at that date, while operating cash flow was negative USD 603,021 in the second quarter of 2026.

Two dates shape the vote

Proxy materials must be received by 11:59 p.m. Eastern Time on October 29, 2026. The extraordinary general meeting follows on October 30, 2026, at 9:00 a.m. Eastern Time, according to the SEC filing.

EUDA stays tied to Nasdaq

EUDA was last at USD 14.90 on Nasdaq on October 20, 2026 at 4:00 p.m. ET. Its market capitalization was USD 44.6 million, with a 52-week range of USD 5.26 to USD 71.20 as of the same market data snapshot.

EUDA Health Holdings key facts

  • Company: EUDA Health Holdings Limited
  • ISIN: VGG3142E1473
  • Ticker: EUDA
  • Primary exchange: Nasdaq
  • Market capitalization: USD 44.6 million (as of October 20, 2026)
  • 52-week range: USD 5.26-71.20 (as of October 20, 2026)
  • Sector / Industry: Healthcare / Medical - Care Facilities

Market context: Market report S&P 500.

More news and analyses on EUDA Health Holdings stock

Disclaimer...
en | VGG3142E1473 | EUDA | boerse | 70379156 | bgmi